GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Financial Flexibility Index
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Financial Flexibility Index of 0.02x as of September 2023. Free cash flow of Rs362.20 Million (operating CF Rs362.20 Million minus capex Rs0.00) represents 0% of total liabilities (Rs17.31 Billion). Check GlaxoSmithKline Pharmaceuticals Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GlaxoSmithKline Pharmaceuticals Limited Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. For the full cash flow conversion analysis, see GlaxoSmithKline Pharmaceuticals Limited operating cash flow efficiency.
Annual Financial Flexibility Index for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year free cash flow to debt coverage for GlaxoSmithKline Pharmaceuticals Limited. Explore GlaxoSmithKline Pharmaceuticals Limited cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | Rs13.13 Billion | Rs12.90 Billion | Rs21.57 Billion | ▲ +76.6% |
| 2024 | 0.34x | Rs6.13 Billion | Rs5.82 Billion | Rs17.79 Billion | ▲ +3.4% |
| 2023 | 0.33x | Rs5.28 Billion | Rs4.84 Billion | Rs15.85 Billion | ▼ -22.3% |
| 2022 | 0.43x | Rs8.45 Billion | Rs8.11 Billion | Rs19.70 Billion | ▲ +11.3% |
| 2021 | 0.39x | Rs6.22 Billion | Rs5.78 Billion | Rs16.14 Billion | ▼ -21.6% |
| 2020 | 0.49x | Rs6.46 Billion | Rs4.90 Billion | Rs13.15 Billion | ▲ +26.1% |
| 2019 | 0.39x | Rs6.91 Billion | Rs3.99 Billion | Rs17.71 Billion | ▼ -15.9% |
| 2018 | 0.46x | Rs8.76 Billion | Rs4.73 Billion | Rs18.90 Billion | ▼ -14.5% |
| 2017 | 0.54x | Rs5.40 Billion | Rs2.36 Billion | Rs9.97 Billion | ▲ +97.0% |
| 2016 | 0.28x | Rs3.72 Billion | Rs1.39 Billion | Rs13.50 Billion | ▼ -46.4% |
| 2015 | 0.51x | Rs4.01 Billion | Rs2.70 Billion | Rs7.80 Billion | ▲ +72.3% |
| 2014 | 0.30x | Rs3.40 Billion | Rs2.81 Billion | Rs11.40 Billion | ▼ -8.6% |
| 2013 | 0.33x | Rs3.53 Billion | Rs3.14 Billion | Rs10.82 Billion | ▼ -2.4% |
| 2012 | 0.33x | Rs3.78 Billion | Rs3.36 Billion | Rs11.30 Billion | ▼ -42.7% |
| 2011 | 0.58x | Rs5.01 Billion | Rs4.79 Billion | Rs8.59 Billion | ▼ -23.4% |
| 2010 | 0.76x | Rs5.42 Billion | Rs5.12 Billion | Rs7.12 Billion | ▲ +60.3% |
| 2009 | 0.48x | Rs3.54 Billion | Rs3.30 Billion | Rs7.45 Billion | ▼ -6.8% |
| 2008 | 0.51x | Rs3.34 Billion | Rs3.19 Billion | Rs6.55 Billion | ▲ +7.5% |
| 2007 | 0.47x | Rs2.77 Billion | Rs2.59 Billion | Rs5.84 Billion | ▼ -28.4% |
| 2006 | 0.66x | Rs3.73 Billion | Rs3.49 Billion | Rs5.63 Billion | ▲ +36.2% |
| 2005 | 0.49x | Rs2.38 Billion | Rs2.29 Billion | Rs4.90 Billion | — |